MIRX 1801
Alternative Names: MIRX-1801Latest Information Update: 20 Feb 2023
At a glance
- Originator Curamys
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Duchenne muscular dystrophy